Merck Serono Targets Japan's Underdeveloped Fertility Market, Builds Line Extensions On Vital Products
This article was originally published in PharmAsia News
Executive Summary
TOKYO - The pharmaceutical market in Japan is the world's second-largest, but most large companies are pretty well saturated here. Many companies now tout growth projections in China, drawing the regional spotlight away from Japan. But Merck Serono is aggressively promoting its products in Japan, trying to make up for lost time
You may also be interested in...
Where Merck KGAA’s Pipeline Stands
Pipeline review resulted in new focus and products with high value, exec explains.
What Recession? Merck Serono Continues Middle East Expansion Through Innovation And Partnership
Since global biotech giant Merck Serono opened its Middle East regional office in Dubai three years ago, the company has since expanded to four more countries in the region
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).